Irritable Bowel Syndrome (IBS) Epidemiology

The prevalence or the number of persons suffering from irritable bowel syndrome (IBS) is complicated. This is mainly because there is lack of clarity of assessment criteria to differentiate between various functional bowel disorders like irritable bowel syndrome, functional bowel diseases like functional esophageal symptoms, functional dyspepsia and abdominal pain. There is also a lack of clarity between differentiating IBS from chronic gastrointestinal disorders.

The Rome criteria and the Manning criteria

One of the most universally used and accepted methods to define IBS is the Rome criteria and the Manning criteria. Many studies use both these criteria to diagnose IBS and assess the prevalence of the disease.

Who does IBS affect?

Studies show that in North America the prevalence of this condition is between 3 and 20% in most studies and an average of 11.6% as assessed from several studies.

Most studies show that a higher ratio of women who develop IBS compared to men. Commonly the ratio is 2:1.

When age of onset of symptoms is assessed from studies, it is seen that IBS symptoms occurred predominantly in patients younger than 45 years and the prevalence of the symptoms of the disease rose again among the elderly.

Geographically surveys in Israel (among Jews not Bedouins), Iran, and India, China etc. have shown low prevalence of IBS. In China for example prevalence is less than 1%.

Prevalence of IBS

Assessing the prevalence of irritable bowel syndrome as per the predominant symptoms or diarrhea or constipation, it was found that the prevalence of IBS with predominant diarrhea was 5.0 to 5.5% where as the prevalence of IBS with predominant constipation was around 5.2 to 5.4%.

The prevalence of IBS with alternating constipation and diarrhea or mixed IBS with 5.2% as assessed from the studies.

Studies from Korea, Greece, Malaysia, Finland and France showed that there is a wide variation in the prevalence of IBS as per the subclassifications.

Prevalence of psychiatric disorders

Studies have also assessed the factors that contribute to development of IBS including depression, anxiety and sleep disorders like insomnia.

The most common psychiatric disorder associated with IBS is depression, with a prevalence of approximately 30% in IBS patients compared to only 18% in normal healthy population.

Anxiety is also commonly encountered as a condition associated with IBS, with 16% affected compared to healthy populations at a rate of 6%.

Further Reading

Last Updated: May 15, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, May 15). Irritable Bowel Syndrome (IBS) Epidemiology. News-Medical. Retrieved on June 21, 2024 from

  • MLA

    Mandal, Ananya. "Irritable Bowel Syndrome (IBS) Epidemiology". News-Medical. 21 June 2024. <>.

  • Chicago

    Mandal, Ananya. "Irritable Bowel Syndrome (IBS) Epidemiology". News-Medical. (accessed June 21, 2024).

  • Harvard

    Mandal, Ananya. 2023. Irritable Bowel Syndrome (IBS) Epidemiology. News-Medical, viewed 21 June 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Does your lifestyle increase your risk of IBS?